0000313143-13-000185.txt : 20131029
0000313143-13-000185.hdr.sgml : 20131029
20131029192036
ACCESSION NUMBER: 0000313143-13-000185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131028
FILED AS OF DATE: 20131029
DATE AS OF CHANGE: 20131029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LINDOP CHRISTOPHER J
CENTRAL INDEX KEY: 0001266051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 131177482
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION INCORPORATED
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-10-28
0
0000313143
HAEMONETICS CORP
HAE
0001266051
LINDOP CHRISTOPHER J
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
CFO & EVP Business Development
Common Stock
2013-10-28
4
D
0
335.0
39.5514
D
35119
D
Common Stock
2013-10-28
4
D
0
704.0
39.5518
D
34415
D
Common Stock
2013-10-28
4
D
0
655.0
39.5517
D
33760
D
Common Stock
2013-10-28
4
D
0
915.0
39.5514
D
32845
D
Non-Qualified Stock Option (right to buy)
26.315
2009-10-23
2015-10-23
Common Stock
29412
29412
D
Non-Qualified Stock Option (right to buy)
26.47
2010-10-27
2016-10-27
Common Stock
44072
44072
D
Non-Qualified Stock Option (right to buy)
27.495
2011-10-27
2017-10-27
Common Stock
50190
50190
D
Non-Qualified Stock Option (right to buy)
30.67
2012-10-25
2018-10-25
Common Stock
48306
48306
D
Non-Qualified Stock Option (right to buy)
39.055
2013-10-24
2019-10-24
Common Stock
46498
46498
D
Non-Qualified Stock Option (right to buy)
41.66
2014-10-23
2019-10-23
Common Stock
46979
46979
D
Performance Shares
0.0
2017-03-31
2017-12-31
Common Stock
25000
25000
D
Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
By: Alexander Steffan For: Christopher Lindop
2013-10-29